Respiratory Syncytial Virus Vaccination in Solid Organ Transplant Recipients: Interim Findings From a Phase 3 Trial of mRNA-1345

Journal:

Clinical Infectious Diseases

Published:

2026-02-18

DOI:

10.1093/cid/ciag108

Affiliations:

8

Authors:

13

Go to article

Institutions	Authors	Share
Moderna, United States of America (USA)	7.000000	0.54
University of Rochester (UR), United States of America (USA)	1.000000	0.08
Duke University Health System, United States of America (USA)	1.000000	0.08
Henry Ford Hospital, HFHS, United States of America (USA)	1.000000	0.08
University of Alberta (U of A), Canada	1.000000	0.08
University Health Network (UHN), U of T, Canada	1.000000	0.08
UCL, United Kingdom (UK)	0.500000	0.04
Royal Free London NHS Foundation Trust, United Kingdom (UK)	0.500000	0.04

Interested in Immunology?